BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 2470545)

  • 1. [Kinetics of intravenously administered flecainide in patients with acute myocardial infarct].
    Polizzi CA; Carelli M; Giampaolo P; Di Marcotullio G; Tubaro M; Malinconico U; Milazzotto F
    Clin Ter; 1989 Feb; 128(3):183-9. PubMed ID: 2470545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of flecainide in patients with stable ventricular ectopic beats. Multicenter trial of the Italian Study Group on the Electrophysiology of Arrhythmias.
    G Ital Cardiol; 1989 Apr; 19(4):360-70. PubMed ID: 2502464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of flecainide in the therapy of chronic ventricular arrhythmia using the acute oral load method].
    Schwartz PJ; Facchini M; Bonazzi O; Cuspidi C; Priori S; Varisco T; Zuanetti G
    G Ital Cardiol; 1985 Mar; 15(3):273-82. PubMed ID: 4018465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antiarrhythmic efficacy of mexiletine, propafenone and flecainide in ventricular premature beats. A comparative study in patients after myocardial infarction (author's transl)].
    Klempt HW; Nayebagha A; Fabry E
    Z Kardiol; 1982 May; 71(5):340-9. PubMed ID: 6180562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flecainide acetate: concentration-response relationships for antiarrhythmic and electrocardiographic effects.
    Boriani G; Capucci A; Strocchi E; Calliva R; Santarelli A; Biffi M; Magnani B
    Int J Clin Pharmacol Res; 1993; 13(4):211-9. PubMed ID: 8150547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Flecainide: a new antiarrhythmic agent].
    Leclercq JF; Coumel P
    Arch Mal Coeur Vaiss; 1983 Oct; 76(10):1218-30. PubMed ID: 6418100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Short- and medium-term treatment of ventricular hyperkinetic arrhythmia with flecainide].
    Gallicchio F; Aragona PL; Chiatto M; Pugliese F; Donnangelo L
    Clin Ter; 1989 May; 129(3):173-84. PubMed ID: 2527112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of flecainide on chronic ventricular arrhythmias (author's transl)].
    Bluschke V; Breithardt G; Abendroth RR; Seipel L
    Z Kardiol; 1982 Apr; 71(4):284-8. PubMed ID: 6178228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Myocardial infarct and rhythm disorders. II. Acute myocardial infarct and high-risk ventricular hyperkinetic arrhythmias].
    Cossa G; Roncarolo PL; Boccardi A; Giordano MP
    Minerva Cardioangiol; 1983 Mar; 31(3):127-33. PubMed ID: 6190105
    [No Abstract]   [Full Text] [Related]  

  • 10. Mexiletine in the treatment of ventricular arrhythmias.
    Henrard L; Carlier J
    Acta Cardiol Suppl; 1980; (25):127-35. PubMed ID: 6966452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Electrophysiological changes of the excitoconduction system in patients with Chagas cardiomyopathy and their modification by flecainide].
    Abitbol HF; Carrizo Paez R; Derlis Abate C
    Arch Inst Cardiol Mex; 1988; 58(2):107-14. PubMed ID: 2456750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antiarrhythmic treatment with mexiletine in acute myocardial infarction (author's transl)].
    Codecà L; Gruppillo P; Padovan GC; Masoni C; Masoni A
    G Ital Cardiol; 1981; 11(4):477-80. PubMed ID: 7286520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Electrophysiological effects of the new antiarrhythmic drug flecainide (R 818) in man (author's transl)].
    Seipel L; Abendroth RR; Breithardt G
    Z Kardiol; 1981 Jul; 70(7):524-9. PubMed ID: 7269731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Short and intermediate term clinical outcome in patients with cardiogenic shock treated with aortic counterpulsation].
    Fornaro G; Prando MD; Parodi F; Cordero G; Sansa M; Bongo AS; Campi A; Aralda D; Dellavesa P; Aina F; Lazzero M; Cernigliaro C
    G Ital Cardiol; 1996 Dec; 26(12):1385-99. PubMed ID: 9162668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antiarrhythmic therapy with flecainide in acute experimental myocardial infarction (author's transl)].
    Gülker H; Bender F; Brisse B; Thale J; Heuer H; Kristek J; Schindelhauer F; Teerling K
    Z Kardiol; 1981 Feb; 70(2):124-30. PubMed ID: 7222906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Propafenone and flecainide in the therapy of ventricular arrhythmias].
    Paperini L; Davini A; Lattanzi F; Topi A; Reisenhofer B; Squarcini G; Paci A; Topi PL
    Minerva Cardioangiol; 1995 Oct; 43(10):449-57. PubMed ID: 8819814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Arrhythmias during catheterization of patients with acute myocardial infarction (author's transl)].
    Spiel R; Pollak H; Jobst C; Kiss E; Mayer B; Nobis H; Prachar H; Enenkel W
    Wien Klin Wochenschr; 1977 Dec; 89(23):788-92. PubMed ID: 595603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mexiletine therapy of ventricular extrasystoles in the acute phase of myocardial infarction].
    Juillard A; Bouajina A; Barrillon A; Gay J; Gerbaux A
    Ann Cardiol Angeiol (Paris); 1984; 33(2):117-20. PubMed ID: 6201121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Beta-blocker therapy in the management of malignant ventricular arrhythmia in patients with acute myocardial infarction].
    Ma HL; Fang YM; Ma YL; Feng J; Wang KQ; Ge JB
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Apr; 24(4):475-6. PubMed ID: 15090331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hemodynamic effects of propafenone in acute myocardial infarct].
    Finzi A; Ambrosini F; Pagnoni F; Massari FM; Valentini R; Lotto A
    G Ital Cardiol; 1984 May; 14(5):367-72. PubMed ID: 6468818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.